GSK's $13 Billion Novartis Deal Is Only Just the Start

Bookmark
(Bloomberg Gadfly) -- GlaxoSmithKline Plc's new-ish CEO is proving to be an adroit negotiator. On Tuesday, Emma Walmsley agreed to pay $13 billion for Novartis AG's stake in the companies' consumer...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.